✦ LIBER ✦

PMH25 CLINICAL OUTCOMES AND ECONOMIC COSTS OF SECOND-GENERATION ANTIPSYCHOTICS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS

✍ Scribed by A. Berger; S. Kushkuley; K. Sanders; J. Alvir; G. Oster

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes and Costs of Risperidone versus

✍ Montserrat Vera-Llonch; Thomas E Delea; Erin Richardson; Marcia Rupnow; Amy Grog 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Comments to the Editor on “Outcomes and

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Sexual dysfunction associated with secon

✍ Matthew J. Byerly; Paul A. Nakonezny; Brianne Magouirk Bettcher; Thomas Carmody; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Long-term outcomes in chronically hospit

✍ Leonard White; Joseph I. Friedman; Christopher R. Bowie; Martin Evers; Philip D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 151 KB

P.3.075 Hyperprolactinemia in patients w

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 239 KB

An unblinded comparison of the clinical

✍ Hidenobu Suzuki; Keishi Gen; Yuichi Inoue 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 198 KB